Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

被引：69

作者：

Miller, AB

Yurgalevitch, S

Weissfeld, JL

机构：

[1] Deutsch Krebsforschungszentrum, Div Clin Epidemiol, D-6900 Heidelberg, Germany

[2] Westat Inc, Rockville, MD USA

[3] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

来源：

CONTROLLED CLINICAL TRIALS | 2000年 / 21卷 / 06期

关键词：

screening trial; death review;

D O I：

10.1016/S0197-2456(00)00095-7

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well. Control Clin Trials 2000;21:400S-406S (C) Elsevier Science Inc. 2000.

引用

页码：400S / 406S

页数：7

共 5 条

[1]

CHAMBERLAIN J, 1988, LANCET, V2, P411

[2] Cancer surveillance series: Interpreting trends in prostate cancer - Part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality [J].